Characteristics of azole-resistant Aspergillus fumigatus attached to agricultural products imported to Japan.
暂无分享,去创建一个
M. Tashiro | Yuichiro Nakano | T. Miyazaki | T. Takazono | Minori Kikuchi | K. Izumikawa | M. Kikuchi | Maki Mishima | Ryo Urano | N. Ito | Eriko Moriya | Tomoyuki Shirahige
[1] M. Tashiro,et al. Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] D. Hagiwara,et al. Non-cyp51A Azole-Resistant Aspergillus fumigatus Isolates with Mutation in HMG-CoA Reductase , 2018, Emerging infectious diseases.
[3] A. Chowdhary,et al. Triazole resistance surveillance in Aspergillus fumigatus. , 2018, Medical mycology.
[4] Brendan R. Jackson,et al. Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States , 2018, Emerging infectious diseases.
[5] D. Hagiwara,et al. First clinical isolation report of azole-resistant Aspergillus fumigatus with TR34/L98H-type mutation in Japan. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[6] J. Meis,et al. Intercountry Transfer of Triazole-Resistant Aspergillus fumigatus on Plant Bulbs , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] B. Zwaan,et al. A Novel Environmental Azole Resistance Mutation in Aspergillus fumigatus and a Possible Role of Sexual Reproduction in Its Emergence , 2017, mBio.
[8] P. Le Pape,et al. Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia , 2017, Scientific Reports.
[9] A. Chowdhary,et al. Global Population Genetic Analysis of Aspergillus fumigatus , 2017, mSphere.
[10] D. Denning,et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] D. Hagiwara,et al. Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46/Y121F/T289A isolated in Japan. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[12] Catherine Beigelman-Aubry,et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management , 2015, European Respiratory Journal.
[13] W. Melchers,et al. Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] D. Denning,et al. The clinical spectrum of pulmonary aspergillosis , 2014, Thorax.
[15] T. Nishino,et al. Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus , 2012, Antimicrobial Agents and Chemotherapy.
[16] T. Nishino,et al. Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan , 2011, Antimicrobial Agents and Chemotherapy.
[17] W. Melchers,et al. Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology Modeling , 2010, Antimicrobial Agents and Chemotherapy.
[18] J. Mouton,et al. Use of a Novel Panel of Nine Short Tandem Repeats for Exact and High-Resolution Fingerprinting of Aspergillus fumigatus Isolates , 2005, Journal of Clinical Microbiology.
[19] D. Hagiwara,et al. Azole-resistant Aspergillus fumigatus Containing a 34-bp Tandem Repeat in cyp51A Promoter is Isolated from the Environment in Japan. , 2017, Medical mycology journal.